Efficacy and safety of interferon-based therapy in the treatment of adult thalassemic patients with chronic hepatitis C: a 12 years audit

Autor: Irene Vafiadis, Panagiotis Trilianos, Jiannis Vlachogiannakos, Markisia Karagiorga, Antonia Hatziliami, Ersi Voskaridou, Spiros D. Ladas

Publikováno v: Annals of Hepatology, Vol 12, Iss 4, Pp 364-370 (2013)

Background. HCV infection and transfusional iron overload in Thalassemic patients may result in liver disease. HCV treatment in Thalassemia has raised safety concerns.Aim. Estimate effectiveness and tolerability of interferon-based therapy in HCV-inf

Externí odkaz: https://doaj.org/article/d78a955a344640acab55e87947891423

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Greater Biosynthetic Liver Dysfunction in Primary Sclerosing Cholangitis Suggests Co-existent or Impending Cholangiocarcinoma.

Autor: Trilianos P; Department of Gastroenterology & Hepatology, Section of Transplant Hepatology, The Johns Hopkins School of Medicine, Baltimore MD, USA; Department of Medicine, MetroWest Medical Center, Framingham, MA, USA., Agnihotri A; Department of Gastroenterology & Hepatology, Section of Transplant Hepatology, The Johns Hopkins School of Medicine, Baltimore MD, USA., Ucbilek E; Department of Gastroenterology & Hepatology, Section of Transplant Hepatology, The Johns Hopkins School of Medicine, Baltimore MD, USA., Gurakar A; Department of Gastroenterology & Hepatology, Section of Transplant Hepatology, The Johns Hopkins School of Medicine, Baltimore MD, USA.

Publikováno v: Journal of clinical and translational hepatology [J Clin Transl Hepatol] 2016 Mar 28; Vol. 4 (1), pp. 1-4. Date of Electronic Publication: 2016 Mar 15.